jRCT1041240077招募中不适用
Pemafibrate therapy for hyperlipidemia with chronic kidney disease, including dialysis patients
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Kowa
- 入组人数
- 30
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •serum TG more or 150 mg/dL
- •eGFR less than 20mL/min/1.73m2
排除标准
- •(1) Patients with any of the following
- •Patients with malignant tumors
- •Patients on immunosuppressive drugs
- •Patients with contraindications to pemafibrate
- •(2) Other research subjects who are judged by the principal investigator or physician in charge to be unsuitable for the safe conduct of this study.
结局指标
主要结局
-
Percentage of TG concentrations achieving <150 mg/dL at 24 weeks
次要结局
未报告次要终点
研究者
相似试验
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT04616833[Redacted]
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT04945941[Redacted]
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT06733259[Redacted]
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT06422065[Redacted]
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT01164527[Redacted]